目的 基于文獻(xiàn)計(jì)量學(xué)方法分析覆盆子Rubus chingii的研究現(xiàn)狀，把握覆盆子未來(lái)研究方向和發(fā)展趨勢(shì)。方法 檢索中國(guó)知網(wǎng)（CNKI）和Web of Science（WOS）核心合集數(shù)據(jù)庫(kù)中2004年1月1日—2024年4月30日收錄的覆盆子相關(guān)文獻(xiàn)，使用CiteSpace軟件對(duì)年發(fā)文量、期刊分布、作者及機(jī)構(gòu)合作網(wǎng)絡(luò)、關(guān)鍵詞及高被引文獻(xiàn)進(jìn)行可視化分析。結(jié)果 分別納入801篇和115篇符合要求的中英文文獻(xiàn)，且年發(fā)文量整體呈上升趨勢(shì)，中文發(fā)文量多于英文。收錄文獻(xiàn)最多的中英文期刊分別是《中草藥》和Journal of Functional Foods。國(guó)內(nèi)外核心作者分別為劉紅寧、丁盛和Jiang Jianguo、Zhang Tiantian；核心研究機(jī)構(gòu)有江西中醫(yī)藥大學(xué)、浙江中醫(yī)藥大學(xué)藥學(xué)院、臺(tái)州學(xué)院，主要集中于國(guó)內(nèi)。國(guó)內(nèi)外覆盆子研究主要關(guān)注化學(xué)成分、藥理作用、植物基原等方面，但也存在差異，中文研究涉及中醫(yī)藥配伍分析，英文研究注重化學(xué)成分提取分離與活性驗(yàn)證。結(jié)論 抗氧化、抗衰老等藥理作用研究是覆盆子研究領(lǐng)域的熱點(diǎn)，使用數(shù)據(jù)挖掘、網(wǎng)絡(luò)藥理學(xué)等方法探究覆盆子用藥規(guī)律，應(yīng)用生物合成等技術(shù)優(yōu)化覆盆子化學(xué)成分合成體系及藥食同源研究是覆盆子未來(lái)研究的新方向。

Objective To analyze the current research status and grasp the future research direction and development trend of Fupenzi (Rubus chingii) based on bibliometric methods.Methods Searching the literature related to R. chingii published on China National Knowledge Infrastructure (CNKI) and Web of Science (WOS) core collection database from January 1, 2004 to April 30, 2024, CiteSpace software was used to visualize the annual publication volume, journal distribution, authors and institutional collaborative networks, keywords, and highly cited literature.Results A total of 801 Chinese and 115 English literature fulfilling the requirements are included. The annual number of publications related to R. chingii research showed an overall upward trend, with more Chinese publications than English publications. The Chinese and English journals with the most literature included are Chinese Traditional and Herbal Drugs and Journal of Functional Foods, respectively. The core authors of domestic and foreign journals are Liu Hongning, Ding Sheng, Jiang Jianguo, and Zhang Tiantian. R. chingii research institutions are mainly concentrated in China, the core research institutions are Jiangxi University of Chinese Medicine, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, and Taizhou University. Researches on R. chingii at home and abroad focuses on chemical composition, pharmacological action and plant origin. However, there are also some differences: Chinese research involves the compatibility analysis of traditional Chinese medicine, while foreign research emphasizes extraction and activity verification of chemical components.Conclusion Current hotspots of R. chingii research are anti-oxidation, anti-aging and other pharmacological effects. Using data mining and network pharmacology to study the medicinal patterns, and applying biotechnology to optimize the synthetic system of chemical components of R. chingii and homology of medicine and food will be new directions for future research on R. chingii.

G350;R282.71

國(guó)家自然科學(xué)基金項(xiàng)目（U2202213）;國(guó)家自然科學(xué)基金項(xiàng)目（82374098）;浙江中醫(yī)藥大學(xué)科研項(xiàng)目資助（2022JKZKTS10）;浙江省大學(xué)生新苗人才計(jì)劃（2023R410043）